Clinical trial
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
NCT00033072 · National Institute on Drug Abuse (NIDA), NIH · Unknown status
Key facts
| NCT number | NCT00033072 |
|---|---|
| Title | Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 |
| Official title | Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Amphetamine-Related Disorders |
| Intervention type | Drug |
| Interventions | Selegiline |
| Enrollment | 16 |
| Start date | Sep 1, 2001 |
| Completion | Oct 1, 2002 |
| First posted | Apr 8, 2002 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: